MOACM
IMGN

Mutual of America Capital Management’s Immunogen Inc IMGN Stock Holding History

Mutual of America Capital Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-79,000
Closed -$748K – 1719
2018
Q3 		$748K Hold
79,000
– – 0.01% 1117
2018
Q2 		$769K Buy
+79,000
New +$833K 0.01% 1118

Other funds holding IMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Mutual of America Capital Management's IMGN Position: Q4 2018 in Review

Mutual of America Capital Management sold out of Immunogen Inc (IMGN) in Q4 2018, closing a stake of 79,000 shares — an estimated $748K sold.

Mutual of America Capital Management first reported a position in IMGN in Q2 2018 and held it in 2 quarters. The position peaked at $769K in Q2 2018. 200 funds tracked by Wall St. Rank hold IMGN as of Q4 2018.

  • Mutual of America Capital Management reported no remaining Immunogen Inc position as of Q4 2018 after selling out during the quarter.
  • Mutual of America Capital Management sold 79,000 Immunogen Inc shares in Q4 2018, an estimated $748K.
  • Mutual of America Capital Management first reported a position in Immunogen Inc in Q2 2018 and held it in 2 quarters.
  • Mutual of America Capital Management's Immunogen Inc position peaked at $769K in Q2 2018.
  • 200 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2018.

Based on Mutual of America Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.